Publications

• Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches.
  Oncologist Volume: 29 Page(s): 738 - 746
  09/06/2024 Authors: Chukkalore D; MacDougall K; Master V; Bilen MA; Nazha B
• Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study.
  J Natl Cancer Inst Volume: 116 Page(s): 966 - 973
  06/07/2024 Authors: Rose KM; Pham R; Zacharias NM; Ionescu F; Paravathaneni M; Marchetti KA; Sanchez D; Mustasam A; Sandstrom R; Vikram R
• Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
  Clin Genitourin Cancer Volume: 22 Page(s): 102056
  06/01/2024 Authors: Nicaise EH; Schmeusser BN; Ali A; Midenberg E; Palacios AR; Hartsoe B; Kearns E; Ambadi S; Patil DH; Joshi SS
• Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
  Cancer Volume: 129 Page(s): 3884 - 3893
  12/15/2023 Authors: Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI
• Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
  Oncologist Volume: 28 Page(s): 1072 - 1078
  12/11/2023 Authors: Sanda GE; Shabto JM; Goyal S; Liu Y; Martini DJ; Nazha B; Brown JT; Yantorni LB; Anne Russler G; Caulfield S
• The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression.
  Cancers (Basel) Volume: 15
  12/06/2023 Authors: Hadadi A; Krause HB; Elliott A; Brown JT; Nazha B; Harik LR; Carthon BC; Miron B; Nabhan C; Barata PC
• Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
  J Natl Cancer Inst Volume: 115 Page(s): 1605 - 1615
  12/06/2023 Authors: El Zarif T; Nassar AH; Pond GR; Zhuang TZ; Master V; Nazha B; Niglio S; Simon N; Hahn AW; Pettaway CA
• Combined Programmed Death-Ligand 1 and MET Inhibition: Has Papillary Renal Cell Carcinoma MET Its Match?
  J Clin Oncol Volume: 41 Page(s): 2467 - 2470
  05/10/2023 Authors: Brown JT; Nazha B; Bilen MA
• Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
  Oncologist Volume: 28 Page(s): 239 - 245
  03/17/2023 Authors: Zhuang TZ; Ravindranathan D; Liu Y; Martini DJ; Brown JT; Nazha B; Russler G; Yantorni LB; Caulfield S; Carthon BC
• Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
  J Immunother Precis Oncol Volume: 5 Page(s): 52 - 57
  08/01/2022 Authors: Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Hitron EE; Russler GA; Yantorni L; Caulfield S; Brown JT
• Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER-Medicare Database Analysis.
  Cancers (Basel) Volume: 14
  06/30/2022 Authors: Nazha B; Zhang C; Chen Z; Ragin C; Owonikoko TK
• High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells.
  Nat Commun Volume: 13 Page(s): 3385
  06/13/2022 Authors: Boya M; Ozkaya-Ahmadov T; Swain BE; Chu C-H; Asmare N; Civelekoglu O; Liu R; Lee D; Tobia S; Biliya S
• Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials.
  Cancers (Basel) Volume: 14
  06/10/2022 Authors: Zhuang TZ; Case K; Olsen TA; Brown JT; Carthon BC; Kucuk O; Goldman J; Harris W; Bilen MA; Nazha B
• Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
  Oncologist Volume: 27 Page(s): 462 - 468
  06/08/2022 Authors: Nazha B; Zhuang TZ; Dada HI; Drusbosky LM; Brown JT; Ravindranathan D; Carthon BC; Kucuk O; Goldman J; Master VA
• Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer.
  Urol Oncol Volume: 40 Page(s): 271.e9 - 271.e18
  06/01/2022 Authors: Hadadi A; Smith KE; Wan L; Brown JR; Russler G; Yantorni L; Caulfield S; Lafollette J; Moore M; Kucuk O
• Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.
  Clin Genitourin Cancer Volume: 20 Page(s): 53 - 59
  02/01/2022 Authors: Martini DJ; Evans ST; Liu Y; Shabto JM; Uner OE; Olsen TA; Brown JT; Russler GA; Yantorni L; Caulfield S
• Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report.
  Front Oncol Volume: 12 Page(s): 949400
  01/01/2022 Authors: Zhuang TZ; Harik L; Force S; Hadadi A; Bilen MA; Brown JT; Carthon BC; Goldman J; Kucuk O; Master VA
• Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.
  Front Endocrinol (Lausanne) Volume: 13 Page(s): 779915
  01/01/2022 Authors: Olsen TA; Zhuang TZ; Caulfield S; Martini DJ; Brown JT; Carthon BC; Kucuk O; Harris W; Bilen MA; Nazha B
• Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
  Oncologist Volume: 26 Page(s): 1017 - 1025
  12/01/2021 Authors: Martini DJ; Shabto JM; Goyal S; Liu Y; Olsen TA; Evans ST; Magod BL; Ravindranathan D; Brown JT; Yantorni L
• Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options.
  Oncologist Volume: 26 Page(s): 956 - 964
  11/01/2021 Authors: Smith KER; Brown JT; Wan L; Liu Y; Russler G; Yantorni L; Caulfield S; Lafollette J; Moore M; Kucuk O
• Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
  Oncologist Volume: 26 Page(s): e1742 - e1750
  10/01/2021 Authors: Martini DJ; Goyal S; Liu Y; Evans ST; Olsen TA; Case K; Magod BL; Brown JT; Yantorni L; Russler GA
• Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
  J Immunother Cancer Volume: 9
  07/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini D; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni L; Joshi SS
• Circulating interleukin 6, androgen deprivation therapy, and fatigue in prostate cancer: Is inflammation the link?
  Cancer Volume: 127 Page(s): 1371 - 1373
  05/01/2021 Authors: Nazha B; Bilen MA
• Benefits and limitations of real-world evidence: lessons from EGFR mutation-positive non-small-cell lung cancer.
  Future Oncol Volume: 17 Page(s): 965 - 977
  03/01/2021 Authors: Nazha B; Yang JC-H; Owonikoko TK
• Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
  Front Oncol Volume: 11 Page(s): 707050
  01/01/2021 Authors: Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Magod B; Brown JT; Yantorni L; Russler GA; Caulfield S
• Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade.
  Front Oncol Volume: 11 Page(s): 701345
  01/01/2021 Authors: Olsen TA; Martini DJ; Goyal S; Liu Y; Evans ST; Magod B; Brown JT; Yantorni L; Russler GA; Caulfield S
• Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study.
  J Immunother Cancer Volume: 8
  12/01/2020 Authors: Pakkala S; Higgins K; Chen Z; Sica G; Steuer C; Zhang C; Zhang G; Wang S; Hossain MS; Nazha B
• Efficacy and safety of immune checkpoint blockade in self-identified Black patients with advanced non-small cell lung cancer.
  Cancer Volume: 126 Page(s): 5040 - 5049
  12/01/2020 Authors: Nazha B; Goyal S; Chen Z; Engelhart A; Carlisle JW; Beardslee TJ; Gill H; Odikadze L; Liu Y; Mishra MK
• IMMUNE-RELATED ADVERSE EVENTS (IRAES) MAY INDICATE A FAVORABLE PROGNOSIS IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI)
  Volume: 8 Page(s): A380 - A381
  11/01/2020 Authors: Martini D; Evans S; Goyal S; Liu Y; Olsen TA; Magod B; Brown J; Yantorni L; Russler G; Caulfield S
• BODY COMPOSITION MAY BE PROGNOSTIC AND PREDICTIVE OF CLINICAL OUTCOMES IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI)
  Volume: 8 Page(s): A26 - A27
  11/01/2020 Authors: Martini D; Olsen TA; Goyal S; Liu Y; Evans S; Magod B; Brown J; Yantorni L; Russler G; Caulfield S
• EFFICACY OF SEQUENTIAL IMMUNE CHECKPOINT INHIBITION (ICI) IN PATIENTS WITH GENITOURINARY MALIGNANCIES
  Volume: 8 Page(s): A154 - A155
  11/01/2020 Authors: Evans S; Martini D; Magod B; Olsen T; Brown J; Yantorni L; Ravindranathan D; Russler G; Caulfield S; Goldman J
• Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy.
  Front Oncol Volume: 10 Page(s): 1000
  01/01/2020 Authors: Nazha B; Inal C; Owonikoko TK
• An unusual case of struma ovarii causing ovarian torsion during pregnancy.
  J Obstet Gynaecol Volume: 39 Page(s): 716 - 717
  07/01/2019 Authors: Khalife D; Nassif J; Nazha B; Khalifeh I; Khoury S; Khalil A
• Evaluating the role of race in outcome of advanced non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitor (ICI): Our institutional experience.
  Volume: 37
  05/20/2019 Authors: Nazha B; Chen Z; Goyal S; Engelhart A; Carlisle JW; Beardslee T; Gill H; Odikadze L; Liu Y; Mishra MK
• The clinical conundrum of managing relapsed small cell lung cancer.
  Cancer Volume: 125 Page(s): 1022 - 1026
  04/01/2019 Authors: Nazha B; Owonikoko TK
• Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy.
  Am Soc Clin Oncol Educ Book Volume: 39 Page(s): 3 - 10
  01/01/2019 Authors: Nazha B; Mishra M; Pentz R; Owonikoko TK
• Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized Anticoagulation.
  Semin Thromb Hemost Volume: 44 Page(s): 813 - 822
  11/01/2018 Authors: Nazha B; Pandya B; Spyropoulos AC; Kessler CM
• Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
  Circulation Volume: 138 Page(s): 1402 - 1411
  10/02/2018 Authors: Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
• Neutrophil-to-Lymphocyte Ratio as Predictor for Hospital Mortality in Patients with Acute Pulmonary Embolism
  Volume: 197
  01/01/2018 Authors: Mansour W; Karam B; Zaidan J; Kfoury B; Abbasi S; El Bitar S; Nazha B; Esper Z; Chalhoub M
• Heparin-Induced Thrombocytopenia: Are We Ordering Too Much
  Volume: 130
  12/07/2017 Authors: El Bitar S; Moussaly E; Abbasi S; Ghanem S; Nazha B; Garcia G; Terjanian T
• Febrile neutropenia in the nationwide inpatient sample: In-hospital outcomes and impact of cormobidities in 2007-2012.
  Volume: 35
  05/20/2017 Authors: Abbasi S; Nazha B; Moussaly E; Manchanda M; Atallah JP
• Soft Tissue Myoepithelial Carcinoma of the Neck with Spinal Invasion.
  Rare Tumors Volume: 8 Page(s): 6485
  09/05/2016 Authors: Moussaly E; Nazha B; Kedia S; Chang Q; Forte F
• The BRIDGE trial: What the hospitalist should know.
  J Hosp Med Volume: 11 Page(s): 652 - 657
  09/01/2016 Authors: Nazha B; Spyropoulos AC
• Anaplastic lymphoma kinase inhibitors in elderly patients with advanced non-small cell lung cancer.
  Expert Rev Anticancer Ther Volume: 16 Page(s): 877 - 883
  08/01/2016 Authors: Zaarour M; Nazha B; Weerasinghe C; Moussaly E; Terjanian T
• Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?
  World J Gastrointest Surg Volume: 7 Page(s): 370 - 377
  12/27/2015 Authors: Nazha B; Moussaly E; Zaarour M; Weerasinghe C; Azab B
• Primary Non-Hodgkin's Lymphoma of the Spine: A Case Report and Literature Review.
  World J Oncol Volume: 6 Page(s): 459 - 463
  10/01/2015 Authors: Moussaly E; Nazha B; Zaarour M; Atallah JP
• Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome.
  Case Rep Hematol Volume: 2015 Page(s): 161764
  01/01/2015 Authors: Nazha B; Garcia G; Kandov R; Odaimi M
• Students' perceptions of peer-organized extra-curricular research course during medical school: a qualitative study.
  PLoS One Volume: 10 Page(s): e0119375
  01/01/2015 Authors: Nazha B; Salloum RH; Fahed AC; Nabulsi M
• Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer.
  Expert Rev Anticancer Ther Volume: 15 Page(s): 1327 - 1336
  01/01/2015 Authors: Zaarour M; Weerasinghe C; Nazha B; Hassan S; Atallah J-P
• Aberrant nuclear repressor coreceptor 1 localization in human retinoblastoma.
  Ophthalmic Res Volume: 49 Page(s): 171 - 176
  01/01/2013 Authors: Nazha B; Granner T; Maloney S; Odashiro AN; Antecka E; Burnier MN